In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘TargetedTherapy’ clear

  • Seven major U.S. and European cancer institutions including Dana-Farber are banding together to study the massive amounts of data produced by sequencing tests in an effort to improve treatment decisions.

Tags: TargetedTherapy

Tags: TargetedTherapy

  • Dr. Pasi Jänne led a study that showed a drug shrank lung tumors in 61 percent of patients whose cancers had developed the T790-M resistance mutation. He also commented on personalized medicine for cancer patients.

Tags: LungCancer, TargetedTherapy

  • Dr. Barrett Rollins commented in The Journal of the American Medical Association about how precision medicine has helped patients at Dana-Farber.

Tags: Genomics, TargetedTherapy

  • Dr. Edward J. Benz, Jr., talked about research to develop treatments for cancer that are more efficient and less toxic, by specifically targeting tumors using genetic analysis.


Tags: BasicResearch, TargetedTherapy

  • Dr. Charles Fuchs led a study of ramucirumab, the first targeted drug for advanced stomach cancer to secure FDA approval.

Tags: TargetedTherapy

  • MolecularMD has obtained patent rights to technology—jointly owned by researchers at Dana-Farber and the Broad Institute. MolecularMD said it is developing diagnostic assays for use in clinical trials exploring the efficacy of targeted therapies.

Tags: BasicResearch, TargetedTherapy, Genetics

  • Dr. Ken Anderson discusses new targeted medicines for the treatment of myeloma. Dr. Anderson is leading an international study to determine whether these new drugs could mean risky transplants aren't needed any more.

Tags: MultipleMyeloma, TargetedTherapy

  • Dana-Farber researchers, including Dr. Rameen Beroukhim, have identified DNA mutations that appear to drive about 15 percent of meningiomas, a finding that could lead to the first effective drug treatments for these brain tumors.

Tags: TargetedTherapy, BrainTumors

  • Dr. Bruce E. Johnson said researchers at Foundation Medicine in Cambridge, Mass., have been routinely testing for certain "alterations" in cancer cells to help target treatments and new technologies.

Tags: Genomics, TargetedTherapy

Showing 1-10 of 13 items